Real-world evidence on health resource use among patients with haemophilia and inhibitor exhibiting severe bleeding episodes.

Haemophilia : the Official Journal of the World Federation of Hemophilia
Ampaiwan ChuansumritHaemophilia Inhibitor Study Group

Abstract

This study aimed to explore real-world evidence on health resource use (HRU) spending on patients with haemophilia and inhibitor. Medical records from 1990 to 2019 of patients with haemophilia and inhibitor from three comprehensive haemophilia treatment centres were retrospectively retrieved. In all, 31 patients with haemophilia (A = 30, B = 1) and inhibitor ≥5 BU were included. The mean initial inhibitor of 95.4 BU was detected at the mean age of 6.7 years. The mean number of annual hospitalisations was 3.9. A total of 795 bleeding episodes (major =125, minor =670) were evaluated. The treatment included bypassing agents or plasma exchange before administering high-dose factor VIII concentrate and intervention or surgery. Six patients succumbed to bleeding at the mean age of 17.2 years. Nineteen surviving patients experienced multiple morbidity except six patients with successful and partially successful immune tolerance induction (ITI). The mean (SD) annual total medical consumption for episodic treatment and successful ITI per patient with haemophilia A were 30,804 (81,332) USD and 55,531 (100,566) USD, respectively. Only episodic treatment was paid by the government budget for limited amounts of bypassing agents. Management ...Continue Reading

References

Nov 23, 1991·Lancet·P ChiewsilpS Stabunswadigan
Sep 1, 1999·Haemophilia : the Official Journal of the World Federation of Hemophilia·H ChangJ M Teitel
Sep 30, 2000·Haemophilia : the Official Journal of the World Federation of Hemophilia·A ChuansumritP Hathirat
Aug 30, 2002·Haemophilia : the Official Journal of the World Federation of Hemophilia·P GautierA M Berthier
Nov 4, 2004·British Journal of Haematology·Nigel S Key
Apr 7, 2005·Haemophilia : the Official Journal of the World Federation of Hemophilia·R ParameswaranUNKNOWN HTRS Registry Investigators
Nov 25, 2006·Haemophilia : the Official Journal of the World Federation of Hemophilia·M Ullman, W K Hoots
Jan 11, 2007·Haemophilia : the Official Journal of the World Federation of Hemophilia·A ChuansumritS Pakakasama
Aug 21, 2007·Haemophilia : the Official Journal of the World Federation of Hemophilia·D M DiMicheleE Santagostino
Apr 5, 2008·Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis·Ampaiwan ChuansumritPakawan Wongwerawattanakoon
Aug 2, 2008·Haemophilia : the Official Journal of the World Federation of Hemophilia·M FranchiniM Cruciani
Sep 30, 2008·Blood·Christine L Kempton, Gilbert C White
Mar 27, 2009·Journal of Thrombosis and Haemostasis : JTH·P W CollinsUNKNOWN UK Haemophilia Centre Doctors' Organisation
Jul 1, 2009·Haemophilia : the Official Journal of the World Federation of Hemophilia·M V RagniUNKNOWN Hemophilia Inhibitor Study
Jul 16, 2010·Haemophilia : the Official Journal of the World Federation of Hemophilia·J AstermarkW Keith Hoots
Feb 18, 2011·Haemophilia : the Official Journal of the World Federation of Hemophilia·A GringeriUNKNOWN European Haemophilia Treatment Standardisation Board (EHTSB)
Apr 8, 2011·Blood·Charles R M HayUNKNOWN United Kingdom Haemophilia Centre Doctors' Organisation (UKHCDO)
Oct 14, 2011·Haemophilia : the Official Journal of the World Federation of Hemophilia·P de MoerlooseC Hermans
Nov 3, 2011·Haemophilia : the Official Journal of the World Federation of Hemophilia·L A ValentinoM P Luo
Nov 22, 2011·Blood·Charles R M HayUNKNOWN International Immune Tolerance Study
Jul 11, 2012·Haemophilia : the Official Journal of the World Federation of Hemophilia·A SrivastavaUNKNOWN Treatment Guidelines Working Group on Behalf of The World Federation Of Hemophilia
Nov 20, 2012·British Journal of Haematology·Peter W CollinsUNKNOWN UK Haemophilia Centre Doctors
Apr 3, 2013·Methods in Molecular Biology·Elizabeth DuncanAlison Street
Apr 23, 2013·Haemophilia : the Official Journal of the World Federation of Hemophilia·A ChuansumritW Sasanakul
Apr 1, 1996·Haemophilia : the Official Journal of the World Federation of Hemophilia·A ChuansumritP Isarangkura
Dec 23, 2017·British Journal of Haematology·Rolf C R Ljung
Apr 29, 2018·Orphanet Journal of Rare Diseases·P L F GiangrandeUNKNOWN European Haemophilia Consortium (EHC) and the European Association for Haemophilia and Allied Disorders (EAHAD)
Aug 4, 2020·Haemophilia : the Official Journal of the World Federation of Hemophilia·Alok SrivastavaUNKNOWN WFH Guidelines for the Management of Hemophilia panelists and co-authors

❮ Previous
Next ❯

Citations

May 30, 2021·Haemophilia : the Official Journal of the World Federation of Hemophilia·Benjamin J Samelson-JonesLeslie Raffini

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood Clotting Disorders

Thrombophilia includes conditions with increased tendency for excessive blood clotting. Blood clotting occurs when the body has insufficient amounts of specialized proteins that make blood clot and stop bleeding. Here is the latest research on blood clotting disorders.

Related Papers

Haemophilia : the Official Journal of the World Federation of Hemophilia
F Peyvandi, M Makris
British Journal of Haematology
C A Ludlam
Journal of the Royal College of Physicians of London
R Biggs
Bibliotheca Haematologica
A PavlovskyM De Tezanos Pinto
© 2021 Meta ULC. All rights reserved